-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anti-CEA-CAR-T Cells in Small Intestine Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anti-CEA-CAR-T Cells in Small Intestine Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anti-CEA-CAR-T Cells in Small Intestine Cancer Drug Details: The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anti-CEA-CAR-T Cells in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anti-CEA-CAR-T Cells in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anti-CEA-CAR-T Cells in Metastatic Colorectal Cancer Drug Details: The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anti-CEA-CAR-T Cells in Metastatic Adenocarcinoma of The Pancreas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anti-CEA-CAR-T Cells in Metastatic Adenocarcinoma of The Pancreas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anti-CEA-CAR-T Cells in Metastatic Adenocarcinoma of The...
-
Company Insights
NewDongguan TT Medical Inc Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Dongguan TT Medical Inc Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Dongguan TT Medical Inc is a biomedical company focused on manufacturing, research and development in the fields of peripheral, cardiovascular neurovascular, pulmonary and digest tract series devices. The company is headquartered in Dongguan City, Guangdong, China. GlobalData's Medical Devices company profile report, “Dongguan TT Medical Inc Pipeline Insight and Competitive Landscape, 2024" provides information about the company overview...
-
Company Insights
NewMauna Kea Technologies SAS Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Mauna Kea Technologies SAS Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Mauna Kea Technologies SAS (MKT), is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides a confocal laser endomicroscopy platform. MKT’s Cellvizio is an endomicroscopy platform that provides microscopic images of tissue instantaneously and in a minimally-invasive way. The company also offers vasculature and vasodynamics...
-
Product Insights
Likelihood of Approval Analysis for Cholestasis
Overview How likely is it that the drugs in Cholestasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cholestasis Overview Cholestasis is the slowing or stalling of bile flow from liver....
-
Product Insights
Likelihood of Approval Analysis for Diabetic Gastroparesis
Overview How likely is it that the drugs in Diabetic Gastroparesis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Gastroparesis Overview Gastroparesis is a long-term complication of diabetes that involves...
-
Product Insights
Likelihood of Approval Analysis for Metastatic Adenocarcinoma of The Pancreas
Overview How likely is it that the drugs in Metastatic Adenocarcinoma of The Pancreas will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Adenocarcinoma of The Pancreas Overview Metastatic adenocarcinoma is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bevacizumab in Malignant Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bevacizumab in Malignant Mesothelioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bevacizumab in Malignant Mesothelioma Drug Details: Bevacizumab (Avastin) is a recombinant...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bevacizumab in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bevacizumab in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bevacizumab in Colorectal Cancer Drug Details: Bevacizumab (Avastin) is a recombinant...